Neurosteroids and infantile spasms: The deoxycorticosterone hypothesis

Michael A Rogawski, Doodipala S. Reddy

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Deoxycorticosterone (DOC) is a mineralocorticoid precursor that has anticonvulsant properties in animals and possibly also in humans. Studies indicate that the anticonvulsant activity of DOC requires its enzymatic conversion to 5a,3a-tetrahydrodeoxycorticosterone (THDOC), a neurosteroid that lacks classical hormonal properties but acts as a powerful positive allosteric modulator of GABAA receptors. DOC can be considered a stress hormone because its synthesis is under the control of ACTH. Therefore, stress-induced fluctuations in seizure susceptibility could in part result from alterations in DOC availability. Also, the therapeutic activity of ACTH in infantile spasms could partially relate to its stimulatory effects on the synthesis of DOC, which then undergoes biotransformation to neurosteroids. The recent demonstration that the synthetic neurosteroid analog ganaxolone reduces spasm frequency in children with intractable infantile spasms suggests that neurosteroid-related anticonvulsants may offer a potential new nonhormonal approach for the treatment of infantile spasms and other developmental epilepsies. In addition, it further confirms the utility of pharmacological enhancement of GABA-mediated inhibition in the control of infantile spasms.

Original languageEnglish (US)
Pages (from-to)199-219
Number of pages21
JournalInternational Review of Neurobiology
Volume49
StatePublished - 2002
Externally publishedYes

Fingerprint

Infantile Spasms
Desoxycorticosterone
Neurotransmitter Agents
Anticonvulsants
Adrenocorticotropic Hormone
Mineralocorticoids
Spasm
GABA-A Receptors
Biotransformation
gamma-Aminobutyric Acid
Modulators
Epilepsy
Animals
Seizures
Demonstrations
Availability
Hormones
Pharmacology
Therapeutics

ASJC Scopus subject areas

  • Physiology
  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology
  • Biochemistry
  • Endocrinology

Cite this

Neurosteroids and infantile spasms : The deoxycorticosterone hypothesis. / Rogawski, Michael A; Reddy, Doodipala S.

In: International Review of Neurobiology, Vol. 49, 2002, p. 199-219.

Research output: Contribution to journalArticle

@article{f20e238deb684732883b851e22bb0d54,
title = "Neurosteroids and infantile spasms: The deoxycorticosterone hypothesis",
abstract = "Deoxycorticosterone (DOC) is a mineralocorticoid precursor that has anticonvulsant properties in animals and possibly also in humans. Studies indicate that the anticonvulsant activity of DOC requires its enzymatic conversion to 5a,3a-tetrahydrodeoxycorticosterone (THDOC), a neurosteroid that lacks classical hormonal properties but acts as a powerful positive allosteric modulator of GABAA receptors. DOC can be considered a stress hormone because its synthesis is under the control of ACTH. Therefore, stress-induced fluctuations in seizure susceptibility could in part result from alterations in DOC availability. Also, the therapeutic activity of ACTH in infantile spasms could partially relate to its stimulatory effects on the synthesis of DOC, which then undergoes biotransformation to neurosteroids. The recent demonstration that the synthetic neurosteroid analog ganaxolone reduces spasm frequency in children with intractable infantile spasms suggests that neurosteroid-related anticonvulsants may offer a potential new nonhormonal approach for the treatment of infantile spasms and other developmental epilepsies. In addition, it further confirms the utility of pharmacological enhancement of GABA-mediated inhibition in the control of infantile spasms.",
author = "Rogawski, {Michael A} and Reddy, {Doodipala S.}",
year = "2002",
language = "English (US)",
volume = "49",
pages = "199--219",
journal = "International Review of Neurobiology",
issn = "0074-7742",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Neurosteroids and infantile spasms

T2 - The deoxycorticosterone hypothesis

AU - Rogawski, Michael A

AU - Reddy, Doodipala S.

PY - 2002

Y1 - 2002

N2 - Deoxycorticosterone (DOC) is a mineralocorticoid precursor that has anticonvulsant properties in animals and possibly also in humans. Studies indicate that the anticonvulsant activity of DOC requires its enzymatic conversion to 5a,3a-tetrahydrodeoxycorticosterone (THDOC), a neurosteroid that lacks classical hormonal properties but acts as a powerful positive allosteric modulator of GABAA receptors. DOC can be considered a stress hormone because its synthesis is under the control of ACTH. Therefore, stress-induced fluctuations in seizure susceptibility could in part result from alterations in DOC availability. Also, the therapeutic activity of ACTH in infantile spasms could partially relate to its stimulatory effects on the synthesis of DOC, which then undergoes biotransformation to neurosteroids. The recent demonstration that the synthetic neurosteroid analog ganaxolone reduces spasm frequency in children with intractable infantile spasms suggests that neurosteroid-related anticonvulsants may offer a potential new nonhormonal approach for the treatment of infantile spasms and other developmental epilepsies. In addition, it further confirms the utility of pharmacological enhancement of GABA-mediated inhibition in the control of infantile spasms.

AB - Deoxycorticosterone (DOC) is a mineralocorticoid precursor that has anticonvulsant properties in animals and possibly also in humans. Studies indicate that the anticonvulsant activity of DOC requires its enzymatic conversion to 5a,3a-tetrahydrodeoxycorticosterone (THDOC), a neurosteroid that lacks classical hormonal properties but acts as a powerful positive allosteric modulator of GABAA receptors. DOC can be considered a stress hormone because its synthesis is under the control of ACTH. Therefore, stress-induced fluctuations in seizure susceptibility could in part result from alterations in DOC availability. Also, the therapeutic activity of ACTH in infantile spasms could partially relate to its stimulatory effects on the synthesis of DOC, which then undergoes biotransformation to neurosteroids. The recent demonstration that the synthetic neurosteroid analog ganaxolone reduces spasm frequency in children with intractable infantile spasms suggests that neurosteroid-related anticonvulsants may offer a potential new nonhormonal approach for the treatment of infantile spasms and other developmental epilepsies. In addition, it further confirms the utility of pharmacological enhancement of GABA-mediated inhibition in the control of infantile spasms.

UR - http://www.scopus.com/inward/record.url?scp=0036355147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036355147&partnerID=8YFLogxK

M3 - Article

C2 - 12040893

AN - SCOPUS:0036355147

VL - 49

SP - 199

EP - 219

JO - International Review of Neurobiology

JF - International Review of Neurobiology

SN - 0074-7742

ER -